These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26306488)

  • 1. [What are the health benefits of the most expensive healthcare system in Europe?].
    Mackenbach JP
    Ned Tijdschr Geneeskd; 2015; 159():A9433. PubMed ID: 26306488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Austria: health system review.
    Hofmarcher MM; Quentin W
    Health Syst Transit; 2013; 15(7):1-292. PubMed ID: 24334772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging diseases--do they prevent preventive health care from saving costs?
    Gandjour A
    Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
    Tsiachristas A; Burgers L; Rutten-van Mölken MP
    Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential health gains and health losses in eleven EU countries attainable through feasible prevalences of the life-style related risk factors alcohol, BMI, and smoking: a quantitative health impact assessment.
    Lhachimi SK; Nusselder WJ; Smit HA; Baili P; Bennett K; Fernández E; Kulik MC; Lobstein T; Pomerleau J; Boshuizen HC; Mackenbach JP
    BMC Public Health; 2016 Aug; 16():734. PubMed ID: 27495151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why prevention can increase health-care spending.
    Temple NJ
    Eur J Public Health; 2012 Oct; 22(5):618-9. PubMed ID: 21914705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do drugs reduce utilisation of other healthcare resources?
    Crémieux PY; Ouellette P; Petit P
    Pharmacoeconomics; 2007; 25(3):209-21. PubMed ID: 17335307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
    Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
    Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of medical spending in the United States, 1960-2000.
    Cutler DM; Rosen AB; Vijan S
    N Engl J Med; 2006 Aug; 355(9):920-7. PubMed ID: 16943404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismarck or Beveridge: a beauty contest between dinosaurs.
    van der Zee J; Kroneman MW
    BMC Health Serv Res; 2007 Jun; 7():94. PubMed ID: 17594476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs.
    Rasmussen SR; Thomsen JL; Kilsmark J; Hvenegaard A; Engberg M; Lauritzen T; Søgaard J
    Scand J Public Health; 2007; 35(4):365-72. PubMed ID: 17786799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in life expectancy among Australians due to reductions in smoking: Results from a risk percentiles approach.
    Mannan H; Curtis AJ; Forbes A; Magliano DJ; Lowthian JA; Gambhir M; McNeil JJ
    BMC Public Health; 2016 Jan; 16():77. PubMed ID: 26813029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Smoking Prevention Framework Approach (EFSA): an example of integral prevention.
    de Vries H; Mudde A; Leijs I; Charlton A; Vartiainen E; Buijs G; Clemente MP; Storm H; González Navarro A; Nebot M; Prins T; Kremers S
    Health Educ Res; 2003 Oct; 18(5):611-26. PubMed ID: 14572020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cost per year of life gained: trends and internal contradictions].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2467-70. PubMed ID: 17137090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing fatal diseases increases healthcare costs: cause elimination life table approach.
    Bonneux L; Barendregt JJ; Nusselder WJ; der Maas PJ
    BMJ; 1998 Jan; 316(7124):26-9. PubMed ID: 9451262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life expectancy and national income in Europe, 1900-2008: an update of Preston's analysis.
    Mackenbach JP; Looman CW
    Int J Epidemiol; 2013 Aug; 42(4):1100-10. PubMed ID: 23920140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the contribution of changes in healthcare expenditures and smoking to the reversal of the trend in life expectancy in the Netherlands.
    Peters F; Nusselder WJ; Reibling N; Wegner-Siegmundt C; Mackenbach JP
    BMC Public Health; 2015 Oct; 15():1024. PubMed ID: 26444672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cigarette smoking on life expectancy between 1980 and 2010: a global perspective.
    Rentería E; Jha P; Forman D; Soerjomataram I
    Tob Control; 2016 Sep; 25(5):551-7. PubMed ID: 26307052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease prevention: saving lives or reducing health care costs?
    Grootjans-van Kampen I; Engelfriet PM; van Baal PH
    PLoS One; 2014; 9(8):e104469. PubMed ID: 25116681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.